CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research ...
Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a ...
(RTTNews) - Abcam Plc (ABCM, ABC.L), a supplier of life science research tools, announced Monday that it has entered into a definitive agreement to acquire BioVision, Inc., a unit of Boai NKY Medical ...
(Sharecast News) - Abcam said on Monday that it has agreed to buy California-based BioVision for $340m. The deal, which is expected to be accretive to earnings from the first full year of ownership ...
Dr David Amudavi, Executive Director, Biovision Africa Trust (right) and Andreas Schriber, Board Chair, Biovision Africa Trust during the launch of the organization's strategic plan in Nairobi.
2 August 2021, Cambridge, UK – Abcam plc ("Abcam", “the Company” or "the Group") (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that it has ...
BioVision started supplying Abcam in 2003, and the transaction represents a compelling strategic fit for Abcam. Abcam plans to fund the acquisition from existing cash resources and a partial drawdown ...
Founded in 1999 and located in Milpitas, California, BioVision is a global supplier of life science research tools to support research, diagnostics, and drug discovery. The company is a leading ...
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results